Catheter-related Bloodstream Infections Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET ANALYSIS
Catheter-related bloodstream infections may occur due to bacteraemia at the tip of the catheter or between peripheral intravenous catheters. These catheter-related bloodstream infections are the most lethal, recurring, and cost-complex expenses because of high maintenance at the hospital for the infected patient. The cause of this is a multidrug-resistant pathogen acquired through invasive procedures, improper or uncontrolled use of antibiotics, and not following appropriate infection control practices called "nosocomial infections," also known as healthcare-associated infections. Intravascular and peripheral IV catheters are the cause of infection.
GROWTH DRIVERS AND CHALLENGES
Factors driving the catheter-related bloodstream infections (CRBSI) market growth are the increase in the occurrence of bloodstream infections, the rise in invasive medical procedures, and the growing adoption of advanced equipment. Invasive procedures often require the use of catheters, such as central venous catheters, urinary catheters, or dialysis catheters, which are inserted into the body for various purposes. Catheters also present a potential entry point for bacteria and other pathogens, leading to bloodstream infections. The rise in invasive medical procedures has had a direct impact on driving the catheter-related bloodstream infections market. The increased recognition of CRBSI risks and the need to improve patient outcomes have led to advancements in infection prevention strategies and the development of innovative products. The market continues to evolve as healthcare providers and manufacturers work together to reduce the incidence of CRBSIs and enhance patient safety in invasive procedures. Thus, the rise in the number of invasive medical procedures is fueling the catheter-related bloodstream infection market growth.
The absence of a surveillance system for infections associated with healthcare and these reasons often leads to problems in identifying such infections, as it is very challenging to set uniform diagnostic criteria. These are the key drivers and restraints of the catheter-related bloodstream infections market.
REPORT SEGMENTATION AND SCOPE
The "Global Catheter-related bloodstream infections Market Analysis to 2031" is a specialized and in-depth study with a major focus on the global catheter-related bloodstream infections market trends and growth opportunities. The report aims to provide an overview of the global catheter-related bloodstream infections market with detailed market segmentation by treatment type, source of infection, distribution channel, and geography. The global catheter-related bloodstream infections market has been witnessing high growth over the recent past and is expected to continue this trend during the forecast period. The report provides key statistics on the use of catheter-related bloodstream infections worldwide along with their demand in major regions and countries. In addition, the report provides the qualitative assessment of various factors affecting the catheter-related bloodstream infections market performance in major regions and countries. The report also includes a comprehensive analysis of the leading players in the catheter-related bloodstream infections market and their key strategic developments. Several analyses on the market dynamics are also included to help identify the key driving factors, market trends, and lucrative catheter-related bloodstream infections market opportunities that would, in turn, aid in identifying the major revenue pockets.
Further, ecosystem analysis and Porter's five forces analysis provide a 360-degree view of the global catheter-related bloodstream infections market. This helps understand the entire supply chain and various factors affecting the market growth.
SEGMENTAL ANALYSIS
The global catheter-related bloodstream infections market is segmented based on treatment type, source of infection, and distribution channel. Based on treatment type, the catheter-related bloodstream infections market is bifurcated into as anti-microbial agents and antibiotic lock therapy. On the basis of source of infection, the market is classified as coagulase-negative staphylococcus, s.aureus, enteric gram-negative bacilli, yeasts, enterococci & streptococci, pseudomonas, and others. The catheter-related bloodstream infections market is categorized based on distribution channel into hospital pharmacies, retail pharmacies, and online pharmacies.
Based on treatment type, the anti-microbial agents accounted for a significant catheter-related bloodstream infections market share which can be attributed to its popularity across the globe and wide availability. There are bloodstream infections caused by the presence of different types of antimicrobial agents that inhibit the colonization of catheters with pathogenic microbes and prevent CAUTIs (Catheter-associated urinary tract infections). The antimicrobial catheter, however, has several characteristics, e.g., its release of antimicrobials, changes in the surface of the catheter, contact killing, destruction of biofilm formation, and use of bacterial biofilms to prevent pathogen colonization. Despite these characteristics, urinary tract infections caused by antibacterial catheters are not decreasing. Therefore, antimicrobial catheters are predicted to have a higher market share in blood infections associated with catheters due to the reasons given above. Thus, the anti-microbial agents segment drives the growth of catheter-related bloodstream infections market share.
REGIONAL ANALYSIS
The report provides a detailed overview of the global catheter-related bloodstream infections market with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. North America is estimated to account for a significant catheter-related bloodstream infections market share globally due to technological advances in blood-borne infection treatment and strong healthcare infrastructure, this trend is expected to prevail over the forecast period. Increasing numbers of American and Canadian patients with catheter blood infections, especially in the elderly, drive North America's market.
INDUSTRY DEVELOPMENTS AND FUTURE OPPORTUNITIES
Partnership, acquisitions and new product launches were found to be the major strategies adopted by the players operating in the global catheter-related bloodstream infections market.
In February 2021, CorMedix, Inc. announced that Neutrolin received grant from the U.S. Food and Drug Administration for the prevention of catheter-related blood stream infections (CRBSIs) in hemodialysis patients.
In April 2023, Citius Pharmaceuticals, Inc., a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, announced that it has advanced its clinical trial for Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections.
IMPACT OF COVID/IMPACT OF GEOPOLITICAL SCENARIO/IMPACT OF RECESSION
The COVID-19 pandemic significantly influenced the global market for catheter-related bloodstream infections. CRBSIs pose a higher risk due to increased demand for healthcare resources and strong pressure on healthcare systems. In addition, measures to control infections and increased use of catheters in COVID-19 patients reinforce the need for efficient prevention strategies. This analysis draws awareness to the impact of pandemics on the market and analyses how actions have been taken against CRBSI risks in these difficult times.
COMPETITIVE LANDSCAPE AND KEY COMPANIES
Some of the key players operating in the catheter-related bloodstream infections market include Merck Sharp & Dohme Corp, CorMedix, Inc., Geistlich Pharma AG, Pfizer, Glenmark Pharmaceuticals Ltd., Fresenius Medical Care, Taurophar GmbH, Citus Pharmaceuticals, AstraZeneca Pharma India Ltd., Xellia Pharmaceuticals Ltd. among others.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Table of Content
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Catheter-related Bloodstream Infections Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Catheter-related Bloodstream Infections Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Catheter-related Bloodstream Infections Market - Global Market Analysis
6.1 Catheter-related Bloodstream Infections - Global Market Overview
6.2 Catheter-related Bloodstream Infections - Global Market and Forecast to 2030
7. Catheter-related Bloodstream Infections Market – Revenue Analysis (USD Million) – By Treatment Type, 2020-2030
7.1 Overview
7.2 Anti-microbial Agents
7.3 Antibiotic Lock Therapy
8. Catheter-related Bloodstream Infections Market – Revenue Analysis (USD Million) – By Source of Infection, 2020-2030
8.1 Overview
8.2 Coagulase-negative Staphylococcus
8.3 S.aureus
8.4 Enteric Gram-negative Bacilli
8.5 Yeasts
8.6 Enterococci and Streptococci
8.7 Pseudomonas
8.8 Others
9. Catheter-related Bloodstream Infections Market – Revenue Analysis (USD Million) – By Distribution Channel, 2020-2030
9.1 Overview
9.2 Hospital Pharmacies
9.3 Retail Pharmacies
9.4 Online Pharmacies
10. Catheter-related Bloodstream Infections Market - Revenue Analysis (USD Million), 2020-2030 – Geographical Analysis
10.1 North America
10.1.1 North America Catheter-related Bloodstream Infections Market Overview
10.1.2 North America Catheter-related Bloodstream Infections Market Revenue and Forecasts to 2030
10.1.3 North America Catheter-related Bloodstream Infections Market Revenue and Forecasts and Analysis - By Treatment Type
10.1.4 North America Catheter-related Bloodstream Infections Market Revenue and Forecasts and Analysis - By Source of Infection
10.1.5 North America Catheter-related Bloodstream Infections Market Revenue and Forecasts and Analysis - By Distribution Channel
10.1.6 North America Catheter-related Bloodstream Infections Market Revenue and Forecasts and Analysis - By Countries
10.1.6.1 United States Catheter-related Bloodstream Infections Market
10.1.6.1.1 United States Catheter-related Bloodstream Infections Market, by Treatment Type
10.1.6.1.2 United States Catheter-related Bloodstream Infections Market, by Source of Infection
10.1.6.1.3 United States Catheter-related Bloodstream Infections Market, by Distribution Channel
10.1.6.2 Canada Catheter-related Bloodstream Infections Market
10.1.6.2.1 Canada Catheter-related Bloodstream Infections Market, by Treatment Type
10.1.6.2.2 Canada Catheter-related Bloodstream Infections Market, by Source of Infection
10.1.6.2.3 Canada Catheter-related Bloodstream Infections Market, by Distribution Channel
10.1.6.3 Mexico Catheter-related Bloodstream Infections Market
10.1.6.3.1 Mexico Catheter-related Bloodstream Infections Market, by Treatment Type
10.1.6.3.2 Mexico Catheter-related Bloodstream Infections Market, by Source of Infection
10.1.6.3.3 Mexico Catheter-related Bloodstream Infections Market, by Distribution Channel
Note - Similar analysis would be provided for below mentioned regions/countries
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 Australia
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 South Korea
10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
10.4.1 South Africa
10.4.2 Saudi Arabia
10.4.3 U.A.E
10.4.4 Rest of Middle East and Africa
10.5 South and Central America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Rest of South and Central America
11. Pre and Post Covid-19 Impact
12. Industry Landscape
12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments
13. Competitive Landscape
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration
14. Catheter-related Bloodstream Infections Market - Key Company Profiles
14.1 Merck Sharp and Dohme Corp
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
Note - Similar information would be provided for below list of companies
14.2 CorMedix, Inc.
14.3 Geistlich Pharma AG
14.4 TauroPharm GmbH
14.5 Fresenius Medical Care
14.6 Pfizer
14.7 Glenmark Pharmaceuticals Ltd.
14.8 Citus Pharmaceuticals
14.9 AstraZeneca Pharma India Ltd.
14.10 Xellia Pharmaceuticals Ltd.
15. Appendix
15.1 Glossary
15.2 About The Insight Partners
15.3 Market Intelligence Cloud
NOTES
- The list of companies included in the scope are as per standard report format and the list can be modified/expanded as per client's requirement
- The sequence/list of companies do not represent their current position in the market.
- The list of countries provided in the report are part of standard report and can be customized as per client's requirement.
RELATED REPORTS
- XXXX XXXX Market
- XXXX XXXX Market
The List of Companies
1. Merck Sharp and Dohme Corp
2. CorMedix, Inc.
3. Geistlich Pharma AG
4. TauroPharm GmbH
5. Fresenius Medical Care
6. Pfizer
7. Glenmark Pharmaceuticals Ltd.
8. Citus Pharmaceuticals
9. AstraZeneca Pharma India Ltd.
10. Xellia Pharmaceuticals Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For